IP Library Granted Patent US 8,026,057
Granted Patent B2
US 8,026,057 · App. 12/163,528 · Granted Sep 27, 2011

Nucleic acid labeling compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,026,057
App. No.
12/163,528
Granted
Sep 27, 2011
Kind
B2
Abstract

Nucleic acid labeling compounds are disclosed. The compounds are synthesized by condensing a heterocyclic derivative with a cyclic group (e.g. a ribofuranose derivative). The labeling compounds are suitable for enzymatic attachment to a nucleic acid, either terminally or internally, to provide a mechanism of nucleic acid detection.

Claims (18)

1. A nucleic acid labeling compound having the formula:

wherein A is hydrogen, monophosphate, diphosphate, triphosphate, α-thiotriphosphate, phosphoramidite, or H-phosphonate;

wherein X 1 is O, S, NR 1 or CHR 2 , wherein R 1 and R 2 are, independently, hydrogen, alkyl or aryl;

wherein X 2 is a bond or alkylene;

wherein Q is selected from the group consisting of a radiolabel, a magnetic particle, colloidal gold, fluorescein, texas red, rhodamine, green fluorescent protein, luminal lophine, acridine salts, luciferin, vanadium spin labels, copper spin labels, iron spin labels, manganese spine labels, nitroxide free radicals, quinoline dyes, triarlmethane dyes, acridine dyes, colored glass beads, polystyrene beads, polypropylene beads, latex beads, biotin, horseradish peroxidase, alkaline phosphatase, 1-aminonapthalene, 2-aminonapthalene, p,p′-diaminostilbenes, pyrenes, quaternary phenanthridine salts, 9-aminoacridines, p,p′-diaminobenzophenone imines, anthracenes, oxacarbocyanines, marocyanine, 3-amino aminoequilenin, perylene, bisbenzoxazole, bis-p-oxazolyl benzene, 1,2-benzophenazin, retinol, bis-3-aminopridinium salts, hellebrigenin, tetracyline, sterophenol, benzimidazolyl phenylamine, 2-oxo-3-chromen, indole, xanthen, 7-hydroxycoumarin, phenoxazine, salycilate, strophanthidin, porphyrins, triarylmethanes, flavin, xanthene dyes, rhodamine dyes, cyanine dyes, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene dyes, phycobiliprotein, dansyl chloride, 3,6-dihydroxy-9-phenylxanthhydrol; rhodamineisothiocyanate; N-phenyl-1-amino-8-sulfonatonaphthalene; N-phenyl-2-amino-6-sulfonatonaphthalene; 4-acetamido-4-isothiocyanatostilbene-2,2′-disulfonic acid; pyrene-3-sulfonic acid; 2-toluidinonapththalene-6-sulfonate; N-phenyl, N-methyl 2-aminonaphthalene-6-sulfonate; ethidium bromide; stebrine; auromine-0,2-(9′-anthroyl)palmitate; dansyl phosphatidylethanolamin; N,N′-dioctadecyl oxacarbocycanine; N,N′-dihexyl oxacarbocyanine; merocyanine, 4-(3′-pyrenyl)butryate; d-3-aminodesoxy-equilenin; 12-(9′-anthroyl)stearate; 2-methylanthracene; 9-vinylanthracene; 2,2′-(vinylene-p-phenylene)bisbenzoxazole; p-bis[2-(4-methyl-5-phenyl oxazolyl)]benzene; 6-dimethylamino-1,2-benzophenzin; retinol; bis(3′-aminopyridinium)-1,10-decandiyl diiodide; sulfonaphthylhydrazone of hellibrienin; chlorotetracycline; N-(7-dimethylamino-4-methyl-2-oxo-3-chromenyl)maleimide; N-[p-(2-benzimidazolyl)phenyl]maleimide; N-(4-fluoranthyl)maleimide; bis(homovanillic acid); resazarin; 4-chloro-7-nitro-2,1,3-benzooxadizole; merocyanine 540; resorufin; rose_bengal and 2,4-diphenyl-3(2H)-furanone; and

wherein G is -L-(M) m , wherein L is a linker moiety selected from the group consisting of amido alkyl groups, functionalized alkyl groups, alkenyl alkyl groups, alkanoyl groups, and N-alkyl amido groups, wherein m is an integer from 0 to 20 and each M is a connecting group selected from the group consisting of amino alkyl, —O(CH 2 ) 5 NH—, —CO—, —NH—, —CO(O)—, —CO(NH)—, —(CH 2 ) i O—, —(CH 2 ) j NH—, —C(O)(CH 2 ) h O—, —CO(CH 2 ) 5 NHCO(CH 2 ) 5 NH—, —NH(CH 2 CH 2 O) k NH—, —NH(CH 2 CH 2 O) k CH 2 CH 2 NH— and —CO(CH 2 ) 5 —, wherein k is an integer from 1 to 5, and wherein h, i, and j are independently integers from 1 to 5.

2. The nucleic acid labeling compound of claim 1 , wherein A is H or H 4 O 9 P 3 —;

wherein X 1 is O;

wherein X 2 is a bond; and

wherein G is —C(O)NR 3 —(CH 2 ) m —(CH 2 CH 2 O) n —CH 2 CH 2 —C(O)NR 3 —, wherein R 3 is hydrogen or alkyl, and wherein m and n are independently an integer from 1 to 15.

3. The nucleic acid labeling compound of claim 2 , wherein G is —C(O)NH—(CH 2 ) m —(CH 2 CH 2 O) n —CH 2 CH 2 —C(O)NH—;

wherein m is from 1 to 6; and

wherein n is from 1 to 4.

4. The nucleic acid labeling compound of claim 1 , wherein A is H or H 4 O 9 P 3 —;

wherein X 1 is O;

wherein X 2 is CH 2 ; and

wherein G is —C(O)NR 3 —(CH 2 ) m —(CH 2 CH 2 O) n —CH 2 CH 2 —C(O)NR 3 —, wherein R 3 is hydrogen or alkyl, and wherein m and n are independently an integer from 1 to 15.

5. The nucleic acid labeling compound of claim 4 , wherein G is —C(O)NH—(CH 2 ) m —(CH 2 CH 2 O) n —CH 2 CH 2 —C(O)NH—, wherein m is from 1 to 6, and wherein n is from 1 to 4.

Assignments (4)
NOTICE OF RELEASE Recorded Apr 5, 2016
From: BANK OF AMERICA, N.A.
To: AFFYMETRIX, INC.
Reel/Frame 038361/0891 →
RELEASE OF SECURITY INTEREST Recorded Nov 13, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: AFFYMETRIX, INC.
Reel/Frame 037109/0132 →
SECURITY INTEREST Recorded Oct 28, 2015
From: AFFYMETRIX, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036988/0166 →
SECURITY AGREEMENT Recorded Jun 27, 2012
From: AFFYMETRIX, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028465/0541 →